Dr. Wilcox is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109
Summary
- Dr. Peter Wilcox is an Internal Medicine specialist located in Ann Arbor, MI. He completed his medical education at the University of Washington School of Medicine, graduating in 2020, and pursued residency and chief residency at the University of Michigan from 2021 to 2025. He is currently a Hospital Medicine Attending Physician at Veterans Affairs Ann Arbor Health Care and has been involved as an IM Resident/Chief Resident at the University of Michigan Medical Center. Dr. Wilcox has also worked as a Clinical Research Coordinator at UW Medicine. His research work includes several publications on topics such as SGLT-2 inhibitors post-lung transplantation, ICU transfers, and electronic health records, among others.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 2025 - 2028
University of MichiganChief Residency, Internal Medicine, 2024 - 2025- University of MichiganResidency, Internal Medicine, 2021 - 2024
University of Washington School of MedicineClass of 2020
Certifications & Licensure
MI State Medical License 2024 - 2027
Publications & Presentations
PubMed
- Safety and Tolerability of SGLT-2 Inhibitors Following Lung Transplantation.Peter Wilcox, Krysta Walter, Jonathan Troost, Elizabeth Belloli
Clinical Transplantation. 2025-02-01 - 7 citationsElectronic health records contain dispersed risk factor information that could be used to prevent breast and ovarian cancer.Thomas H. Payne, Lue Ping Zhao, Calvin Le, Peter Wilcox, Troy Yi
Journal of the American Medical Informatics Association. 2020-09-01
Journal Articles
- Safety and Tolerability of SGLT-2 Inhibitors Following Lung TransplantationWilcox P, Walter K, Troost J, Belloli E, Clinical Transplantation, 2/6/2025
Abstracts/Posters
- Safety and Tolerability of SGLT-2 Inhibitors Following Lung TransplantationWilcox P, Walter K, Troost J, Belloli E, American Journal of Respiratory and Critical Care Medicine 2024, 5/2024
- Outcomes of Patients Undergoing Inter-hospital Medical ICU Transfer During Times of StrainP. Wilcox, A. Pastapur, M. Opatrny, A. Curtis, S. Venkatesh, T.S. Valley, Am J Respir Crit Care Med, Washington, DC, 5/23/2023
- Ixazomib-Rituximab in Untreated Indolent B_NHL: An Effective, Very Low Toxicity RegimenSolomon A. Graf, MD , Ryan C. Lynch, MD, Ted A Gooley, PhD, Chaitra S. Ujjani, MD, Peter Wilcox, Sabrina Wilcox, David G. Coffey, MD, Andrew J.Cowan, M.D. , Stephen D...., 62nd ASH Annual Meeting and Exposition, Virtual Meeting, 12/6/2020
- Join now to see all
Press Mentions
Medical Student Scholars Symposium Highlights Wyoming WWAMI Student ResearchJuly 24th, 2022
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
